glp-1 dementia news Can agonists and SGLT-2 inhibitors decrease risk?, Two recent JAMA Neurology studies examined the association., 🔗 Read more via our link in bio NEW STUDY: GLP-1 meds slash

It improves insulin sensitivity, lowers cancer risk, reduces the risk of metabolic syndrome, protects against fatty liver, and keeps your daily calorie burn highereven at rest

Use progress photos, body measurements (waist, hips, thighs), and strength performance (reps, weight lifted) every two to four weeks

We still need to remember that: Lipedema fat is not normal fat. It does not respond to calorie restriction the way typical fat does

After adjustment for maternal age, the number of previous pregnancies and the use of more than one medication, the OR was 0.98 (95% CI, 0.16 to 5.82)

Olfactory dysfunction mediates adiposity in cognitive impairment of type 2 diabetes: insights from clinical and functional neuroimaging studies